Keeler Thomas Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,533
Closed -$265K 126
2025
Q4
$265K Sell
6,533
-14,574
-69% -$634K 0.13% 93
2025
Q3
$993K Buy
21,107
+342
+2% +$17.7K 0.41% 79
2025
Q2
$1.08M Buy
+20,765
New +$1.14M 0.47% 79

Other funds holding CNMD

Keeler Thomas Management's CNMD Position: Q1 2026 in Review

Keeler Thomas Management sold out of CONMED (CNMD) in Q1 2026, closing a stake of 6,533 shares — an estimated $265K sold.

Keeler Thomas Management first reported a position in CNMD in Q2 2025 and held it in 3 quarters. The position peaked at $1.08M in Q2 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Keeler Thomas Management reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Keeler Thomas Management sold 6,533 CONMED shares in Q1 2026, an estimated $265K.
  • Keeler Thomas Management first reported a position in CONMED in Q2 2025 and held it in 3 quarters.
  • Keeler Thomas Management's CONMED position peaked at $1.08M in Q2 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Keeler Thomas Management's 13F filing for Q1 2026, filed 12 May 2026.